FAAH Pharma Inc. announces investment from TVM Life Science Ventures VII to develop new treatment against Neuropathic Pain
11 August 2014 | By B3C newswire
FAAH Pharma Inc., announced an investment by TVM Life Science Ventures VII investment into the company.